Recombinant human galectin-1 (rHsGal-1) has shown efficacy in reducing disease pathologies in murine models of Duchenne Muscular Dystrophy (DMD) through positive regulation of myogenesis and stabilization of the sarcolemma [15]. This evidence concerns the gene LGALS1 and Duchenne muscular dystrophy.